Results 11 to 20 of about 1,376 (142)

Merging two eDNA metabarcoding approaches and citizen‐science‐based sampling to facilitate fish community monitoring along vast Sub‐Saharan coastlines

Molecular Ecology Resources, Volume 23, Issue 7, Page 1641-1655, October 2023., 2023
Abstract The coastline of Sub‐Saharan Africa hosts highly diverse fish communities of great conservation value, which are also key resources for local livelihoods. However, many costal ecosystems are threatened by overexploitation and their conservation state is frequently unknown due to their vast spatial extent and limited monitoring budgets.
Alfred Burian, Kat Bruce, Erica Tovela, Judith Bakker, Laura Balcells, Rhett Bennett, Sarah Chordekar, Hugo M. Costa, Alex Crampton‐Platt, Hugo de Boer, Vere Ross‐Gillespie, Antonio de Sacramento, Naseeba Sidat, Luisa Simbine, Jonathan Ready, Cuong Tang, Quentin Mauvisseau   +16 more
wiley   +1 more source

Evidence of Závora Bay as a critical site for reef manta rays, Mobula alfredi, in southern Mozambique

Journal of Fish Biology, Volume 101, Issue 3, Page 628-639, September 2022., 2022
Abstract The largest known reef manta ray (Mobula alfredi) population in Africa has been monitored for more than 20 years at several locations on the coast of the Inhambane Province in southern Mozambique. Nonetheless, before this study, little had been reported on the population dynamics of M.
Michelle Carpenter, Nakia Cullain, Stephanie Kathleen Venables, Yara Tibiriçá, Charles Griffiths, Andrea Denise Marshall   +5 more
wiley   +1 more source

The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes

Pharmacology Research &Perspectives, Volume 10, Issue 4, August 2022., 2022
Tofogliflozin, a highly specific SGLT2 inhibitor, suppresses atherosclerosis by improving glucose intolerance associated with inhibition of inflammation in the diabetic ApoEKO mice. Abstract Epidemiological and animal studies have revealed that sodium‐glucose cotransporter 2 (SGLT2) inhibitors suppress cardiovascular events in subjects with type 2 ...
Masahiko Iwamoto, Tetsuya Kubota, Yoshitaka Sakurai, Nobuhiro Wada, Seiji Shioda, Toshimasa Yamauchi, Takashi Kadowaki, Naoto Kubota   +7 more
wiley   +1 more source

Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial

Research and Practice in Thrombosis and Haemostasis, Volume 6, Issue 4, May 2022., 2022
Abstract Background Hospitalized patients with COVID‐19 suffered initially from high rates of venous thromboembolism (VTE), with possible associations between therapeutic anticoagulation and better clinical outcomes in observational studies. Objective To test whether therapeutic anticoagulation improves clinical outcomes in severe COVID‐19.
Marc Blondon, Sara Cereghetti, Jérôme Pugin, Christophe Marti, Pauline Darbellay Farhoumand, Jean‐Luc Reny, Alexandra Calmy, Christophe Combescure, Lucia Mazzolai, Olivier Pantet, Zied Ltaief, Marie Méan, Sara Manzocchi Besson, Séverin Jeanneret, Hans Stricker, Helia Robert‐Ebadi, Pierre Fontana, Marc Righini, Alessandro Casini   +18 more
wiley   +1 more source

Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin

Diabetes, Obesity and Metabolism, Volume 23, Issue 7, Page 1660-1665, July 2021., 2021
Abstract Sodium‐glucose cotransporter‐2 inhibitors (SGLT2) are drugs that have been reported to have several effects through the regulation of plasma volume, for example, antihypertensive effects. This study aimed to clarify the impact of long‐term administration and subsequent discontinuation of the SGLT2 inhibitor tofogliflozin on estimated plasma ...
Yasuhiro Matsubayashi, Akihiro Yoshida, Hideki Suganami, Momoko Oe, Takaaki Sato, Yuta Yaguchi, Kazuya Fujihara, Takaho Yamada, Shiro Tanaka, Kohei Kaku, Hirohito Sone   +10 more
wiley   +1 more source

Fog‐to‐Water for Water Scarcity in Climate‐Change Hazards Hotspots: Pilot Study in Southeast Asia

Global Challenges, Volume 5, Issue 5, May 2021., 2021
Water scarcity is the main growing concern in the world. During prolonged drought seasons, fog‐to‐water is one close‐at‐hand freshwater resource. A pilot study on fog‐to‐water solutions in climate‐change hazard hotspots in Southeast Asia is provided.
Zaitizila Ismail, Yun Ii Go
wiley   +1 more source

Predictors of haemoglobin levels and of changes in these levels, focusing on anaemia and polycythaemia after administration of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin

, 2022
Diabetes, Obesity and Metabolism, Volume 24, Issue 12, Page 2469-2473, December 2022.
Yasuhiro Matsubayashi, Alkihiro Yoshida, Hideki Suganami, Momoko Oe, Takaaki Sato, Yuta Yaguchi, Kazuya Fujihara, Takaho Yamada, Shiro Tanaka, Kohei Kaku, Hirohito Sone   +10 more
wiley   +1 more source

Clindamycin resistance of skin derived Staphylococcus pseudintermedius is higher in dogs with a history of antimicrobial therapy

Veterinary Dermatology, Volume 31, Issue 4, Page 305-e75, August 2020., 2020
Background – In the Netherlands there is a lack of data regarding resistance of Staphylococcus pseudintermedius to the systemic antimicrobial drugs used for the treatment of superficial pyoderma. Objectives – To assess antimicrobial resistance, with emphasis on resistance to clindamycin and meticillin, in clinical isolates of S.
Catharina M.M. van Damme, Els M. Broens, Silvia T. Auxilia, Yvette M. Schlotter   +3 more
wiley   +1 more source

Association of increased hepatic insulin clearance and change in serum triglycerides or β‐hydroxybutyrate concentration via the sodium/glucose‐cotransporter 2 inhibitor tofogliflozin

Diabetes, Obesity and Metabolism, Volume 22, Issue 6, Page 947-956, June 2020., 2020
Abstract Aims Obesity and hepatic fat accumulation diminish hepatic insulin clearance, which can cause hyperinsulinaemia. Sodium/glucose‐cotransporter 2 inhibitors (SGLT2‐is) improve insulin resistance and hyperinsulinaemia by weight loss via increased urinary glucose excretion in type 2 diabetes.
Yasuhiro Matsubayashi, Akihiro Yoshida, Hideki Suganami, Taeko Osawa, Kazuo Furukawa, Hiroshi Suzuki, Kazuya Fujihara, Shiro Tanaka, Kohei Kaku, Hirohito Sone   +9 more
wiley   +1 more source

Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss

Diabetes, Obesity and Metabolism, Volume 22, Issue 2, Page 222-230, February 2020., 2020
Abstract Aims To investigate predictors of the initial response of beta‐hydroxybutyrate (BHB) and maximum BHB (max‐BHB) values during long‐term therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin (TOFO), and to explore the association of the initial elevation of BHB with subsequent clinical effects in people with type 2 diabetes ...
Yuichi Sato, Kiyohide Nunoi, Kohei Kaku, Akihiro Yoshida, Hideki Suganami   +4 more
wiley   +1 more source